A Randomized Clinical Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Acute Coronary Syndrome Patients: The TARGET-D Trial – Conference Abstract Only
Comment: I don’t usually review abstracts, but I think this is interesting enough that it’s worth posting at the very least to mark the dosing strategy, which finally mimics what we do clinically. The most compelling takeaway from the TARGET-D trial isn’t just the reduction in recurrent Myocardial Infarction (MI), but how they achieved it: through […]
